Recall report: Zydus recalls herpes drug after crystallization complaints; Alembic pulls low blood pressure drug for incorrect labeling
It’s been a relatively quiet start to the year in terms of drug recalls, but the FDA hit two generics makers late last week for manufacturing issues.
First, Zydus Pharmaceuticals recalled a herpes and shingles drug Thursday after complaints of crystallization in vials.
The administration of crystallized acyclovir sodium injection could cause inflammation of the vein or blood clots, an increase in stroke and heart attack and decreased liver or kidney function, according to the FDA. Zydus hasn’t received any reports of negative reactions connected to the crystallization.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.